These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26604825)

  • 1. Challenges facing effective implementation of co-trimoxazole prophylaxis in children born to HIV-infected mothers in the public health facilities.
    Kamuhabwa AA; Manyanga V
    Drug Healthc Patient Saf; 2015; 7():147-56. PubMed ID: 26604825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of co-trimoxazole preventive therapy policy for malaria in HIV-infected pregnant women in the public health facilities in Tanzania.
    Kamuhabwa AA; Gordian R; Mutagonda RF
    Drug Healthc Patient Saf; 2016; 8():91-100. PubMed ID: 28008284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.
    Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW
    Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial.
    Daniels B; Coutsoudis A; Moodley-Govender E; Mulol H; Spooner E; Kiepiela P; Reddy S; Zako L; Ho NT; Kuhn L; Ramjee G
    Lancet Glob Health; 2019 Dec; 7(12):e1717-e1727. PubMed ID: 31708152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-trimoxazole prophylaxis for children who are HIV-exposed and uninfected: a systematic review.
    Wedderburn CJ; Evans C; Slogrove AL; Rehman AM; Gibb DM; Prendergast AJ; Penazzato M
    J Int AIDS Soc; 2023 Jun; 26(6):e26079. PubMed ID: 37292018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.
    Yazdanpanah Y; Losina E; Anglaret X; Goldie SJ; Walensky RP; Weinstein MC; Toure S; Smith HE; Kaplan JE; Freedberg KA;
    AIDS; 2005 Aug; 19(12):1299-308. PubMed ID: 16052085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anaemia in HIV-infected children at the University of Abuja Teaching Hospital, Gwagwalada.
    Okechukwu AA; Gambo D; Okechukwu IO
    Niger J Med; 2010; 19(1):50-7. PubMed ID: 20232757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late postnatal transmission of human immunodeficiency virus type 1 infection from mothers to infants in Dar es Salaam, Tanzania.
    Karlsson K; Massawe A; Urassa E; Kawo G; Msemo G; Kazimoto T; Lyamuya E; Mbena E; Urassa W; Bredberg-Råden U; Mhalu F; Biberfeld G
    Pediatr Infect Dis J; 1997 Oct; 16(10):963-7. PubMed ID: 9380473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.
    Mermin J; Lule J; Ekwaru JP; Malamba S; Downing R; Ransom R; Kaharuza F; Culver D; Kizito F; Bunnell R; Kigozi A; Nakanjako D; Wafula W; Quick R
    Lancet; 2004 Oct 16-22; 364(9443):1428-34. PubMed ID: 15488218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
    Chintu C; Bhat GJ; Walker AS; Mulenga V; Sinyinza F; Lishimpi K; Farrelly L; Kaganson N; Zumla A; Gillespie SH; Nunn AJ; Gibb DM;
    Lancet; 2004 Nov 20-26; 364(9448):1865-71. PubMed ID: 15555666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations.
    Badri M; Ehrlich R; Wood R; Maartens G
    AIDS; 2001 Jun; 15(9):1143-8. PubMed ID: 11416716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.
    Newell ML; Borja MC; Peckham C;
    Pediatrics; 2003 Jan; 111(1):e52-60. PubMed ID: 12509595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis.
    Okwera A; Mafigiri DK; Guwatudde D; Whalen C; Joloba M
    Afr Health Sci; 2015 Mar; 15(1):49-57. PubMed ID: 25834530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries.
    Zachariah R; Harries AD; Luo C; Bachman G; Graham SM
    Lancet Infect Dis; 2007 Oct; 7(10):686-93. PubMed ID: 17897611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study.
    Mermin J; Ekwaru JP; Liechty CA; Were W; Downing R; Ransom R; Weidle P; Lule J; Coutinho A; Solberg P
    Lancet; 2006 Apr; 367(9518):1256-61. PubMed ID: 16631881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.
    Wiktor SZ; Sassan-Morokro M; Grant AD; Abouya L; Karon JM; Maurice C; Djomand G; Ackah A; Domoua K; Kadio A; Yapi A; Combe P; Tossou O; Roels TH; Lackritz EM; Coulibaly D; De Cock KM; Coulibaly IM; Greenberg AE
    Lancet; 1999 May; 353(9163):1469-75. PubMed ID: 10232312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical predictors of HIV-1 infection among preschool children in Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Simon EE; Mwinula JH; Mbena EC; Samaranayake LP; Scheutz FF
    East Afr Med J; 1995 Nov; 72(11):694-8. PubMed ID: 8904057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
    Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
    N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Experiences with disclosure of HIV-positive status to the infected child": Perspectives of healthcare providers in Dar es Salaam, Tanzania.
    Sariah A; Rugemalila J; Somba M; Minja A; Makuchilo M; Tarimo E; Urassa D; Siril H
    BMC Public Health; 2016 Oct; 16(1):1083. PubMed ID: 27737669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
    Koch A; Kothe H; Braun J; Kämmerer R; Friedrich HJ; Dalhoff K
    Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.